France
  • /
  • Europe
  • Europa
  • Britain
  • Germany
  • Italy
  • Spain
  • Russia
  • Ukraine
  • Africa
  • Tennis
  • FR
    • Afrique
  • France
    • Roland-Garros
  • …
    • Poland
    • Netherlands
    • Iran
    • Canada
    • Australia
    • Japan
  • @
  • Air France
  • Airbus
  • AXA
  • BNP Paribas
  • Bulgari
  • Carrefour
  • Christian Dior
  • CMA CGM
  • Crédit Agricole
  • Dassault Aviation
  • Dassault Systèmes
  • Électricité de France
  • ENGIE
  • Fendi
  • France
  • Hermès
  • L'Oréal
  • Louis Vuitton
  • LVMH
  • Paris
  • Renault
  • Safran
  • Sanofi
  • Schneider Electric
  • Sephora
  • Société Générale
  • Stellantis
  • Thales
  • Tiffany & Co.
  • TotalEnergies
France
  • /
  • Europe
  • Europa
  • Britain
  • Germany
  • Italy
  • Spain
  • Russia
  • Ukraine
  • Africa
  • Tennis
  • FR
    • Afrique
  • France
    • Roland-Garros
  • …
    • Poland
    • Netherlands
    • Iran
    • Canada
    • Australia
    • Japan
  • @

Browsing Tag

1

4 posts
FFrance
Padded bra cheating claim rocks Tour de France Femmes as bizarre theory swirls around cycling
Read More

Padded bra cheating claim rocks Tour de France Femmes as bizarre theory swirls around cycling

  • August 5, 2026
Tour de France Femmes riders are facing allegations of gaining an advantage through the use of padded bras.…
SSanofi
Sanofi Announces Expanded Proactive Care for a Disease Modifying Therapy in Type 1 Diabetes
Read More

Sanofi Announces Expanded Proactive Care for a Disease Modifying Therapy in Type 1 Diabetes

  • July 15, 2026
Sanofi Type 1 Diabetes Approval marks a major step forward in proactive care for adults and children living…
SSanofi
Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
Read More

Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes

  • June 12, 2026
Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3…
SSanofi
Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral IRAK4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration
Read More

Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral IRAK4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration

  • June 9, 2026
First-in-human Phase 1 trial evaluating KT-485 (SAR447971) initiated, triggering a $20 million milestone payment from Sanofi WATERTOWN, Mass.,…
France
www.europesays.com